BioJapan 2023, the largest biopharmaceutical and healthcare exhibition in Japan and Asia, was grandly held at Pacifico Yokohama from October 11-13, 2023. Among the participating Taiwanese companies, the most discussed was Dazzeon Biotech, a company specializing in plant polymer structures as well as material science and enhancing the activity of plant polysaccharides. Over 51 vendors and government organizations approached the company during the three-day exhibition. The focus was on the global markets for plant-based healthcare and sleep-aiding products, with business opportunities of up to tens of billions of NT dollars.
What made the exhibition memorable was a visit to Dazzeon Biotech’s booth by Funayama Co., LTD., Japan’s industry leader in firefighting equipment. The company specializes in rescue and disaster prevention and provides professional disaster prevention training at home and abroad, having assisted Taiwan’s Ministry of the Interior and Fire Department in their disaster rescue drills. Funayama President Masanobu Akiyama, after trying the AlphaSleep product series, said they gave the kind of comfort and warming effect he’d never experienced. Therefore, he invited the Dazzeon Biotech team to have a business meeting at Funayama’s headquarters.
What made the exhibition memorable was a visit to Dazzeon Biotech’s booth by Funayama Co., LTD., Japan’s industry leader in firefighting equipment. The company specializes in rescue and disaster prevention and provides professional disaster prevention training at home and abroad, having assisted Taiwan’s Ministry of the Interior and Fire Department in their disaster rescue drills. Funayama President Masanobu Akiyama, after trying the AlphaSleep product series, said they gave the kind of comfort and warming effect he’d never experienced. Therefore, he invited the Dazzeon Biotech team to have a business meeting at Funayama’s headquarters.
At the exhibition, Dazzeon Biotech also reached cooperation agreement with Japanese institutes such as Hoshi University, the University of Tsukuba, and Tottori University to conduct experiments on the digestive tract and sleep. The institutes also agreed to set up an international R&D center with Dazzeon Biotech in New Taipei City and form an international biotechnology team to conduct in-depth research into digestive tract functions and sleep. Meanwhile, a production center will be established in Japan to facilitate the export of products to Asia and the West.
According to Dazzeon Biotech CEO Dr. Richard Kao, the company achieved fruitful results at the exhibition, but it also attaches great importance to the domestic market, with a core-technology release forecast for Q4. AlphaSleep’s αSleep Blankets with nanonization technology and MannanPRO’s application of plant polysaccharides are two main product lines for the domestic market. Dazzeon Biotech holds an open attitude toward both B2B product co-development and B2C market channel expansion. As long as companies value data verification and aim to bring consumers high-standard, high-quality products and services, they are welcome to approach Dazzeon Biotech for collaboration.
Source：Economic Daily News